Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Antibiotic levels in lungs: key to better pneumonia treatment?

NCT ID NCT03927079

First seen Nov 19, 2025

Summary

This study measures how well certain antibiotics penetrate the lungs in patients with pneumonia. Researchers will compare antibiotic levels in the blood and in lung fluid from 101 adults who need a bronchoscopy. The goal is to find factors that predict good lung penetration, which could help doctors adjust antibiotic doses to improve treatment success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Amiens

    Amiens, 80480, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

beta-lactam antibiotics (e.g., ceftriaxone, amoxicillin-clavulanic acid)

What this could lead to

If successful, this could help doctors choose the right antibiotic dose for lung infections, potentially reducing treatment failures.

What could go wrong

This is an observational study, not a treatment trial. It will not directly test a new drug or cure, and results may not change practice immediately.

Conditions

The condition(s) this trial relates to.

pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.